🧬
Biyoteknoloji Sektörü Hisseleri
Biyoteknoloji Sektörü altında 522 Hisse Senedi
Biyoteknoloji sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
Biyoteknoloji Sektörü Hakkında
Biyoteknoloji sektörü, genetik mühendisliği, ilaç geliştirme ve tıbbi araştırma alanında faaliyet gösteren şirketleri kapsar. Yüksek AR-GE yatırımları ve uzun geliştirme süreçleri ile karakterize edilir.
Temel Özellikler
- Yüksek AR-GE yatırımları
- Uzun geliştirme süreçleri
- Düzenleyici onay riskleri
- Yüksek büyüme potansiyeli
Önemli Şirketler
ModernaGilead SciencesBiogenRegeneron
522
Toplam Hisse
$2.5T
Toplam Piyasa Değeri
Biyoteknoloji Sektörü Hisseleri
Sayfa 2/6 (Toplam: 522)
| SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM | |
|---|---|---|---|---|---|
| SPRY | ARS Pharmaceuticals, Inc. | $1.19B | $14.43 | 6.84% | |
| ETNB | 89bio, Inc. | $1.16B | $9.84 | 0.31% | |
| PCRX | Pacira BioSciences, Inc. | $1.14B | $25.84 | 0.35% | |
| TXG | 10x Genomics, Inc. | $1.14B | $9.53 | 2.09% | |
| DVAX | Dynavax Technologies Corporation | $1.13B | $9.79 | 0.31% | |
| INVA | Innoviva, Inc. | $1.13B | $19.57 | 0.41% | |
| AMPH | Amphastar Pharmaceuticals, Inc. | $1.13B | $25.71 | 0.27% | |
| BLFS | BioLife Solutions, Inc. | $1.10B | $21.88 | 1.97% | |
| OCUL | Ocular Therapeutix, Inc. | $1.09B | $8.01 | 1.60% | |
| PLSE | Pulse Biosciences, Inc. | $1.06B | $17.30 | 3.00% | |
| MDXG | MiMedx Group, Inc. | $1.02B | $6.43 | 1.83% | |
| OPK | OPKO Health, Inc. | $1.02B | $1.36 | 0.00% | |
| IART | Integra LifeSciences Holdings Corporation | $1.01B | $12.66 | 0.16% | |
| ELVN | Enliven Therapeutics, Inc. | $1.00B | $17.77 | 0.17% | |
| GYRE | Gyre Therapeutics, Inc. | $1.00B | $9.07 | 4.12% | |
| MLYS | Mineralys Therapeutics, Inc. | $991.97M | $15.58 | 0.51% | |
| COLL | Collegium Pharmaceutical, Inc. | $959.44M | $29.14 | 0.14% | |
| NVAX | Novavax, Inc. | $954.00M | $7.34 | 2.09% | |
| HROW | Harrow Health, Inc. | $942.45M | $28.11 | 3.35% | |
| RCUS | Arcus Biosciences, Inc. | $898.96M | $8.93 | 6.10% | |
| CDNA | CareDx, Inc | $898.13M | $16.99 | 2.60% | |
| SYRE | Spyre Therapeutics, Inc. | $877.54M | $15.28 | 1.74% | |
| SNDX | Syndax Pharmaceuticals, Inc. | $820.03M | $10.54 | 0.75% | |
| ARDX | Ardelyx, Inc. | $811.07M | $3.67 | 8.93% | |
| NTLA | Intellia Therapeutics, Inc. | $802.25M | $6.87 | 7.79% | |
| CMRX | Chimerix, Inc. | $801.08M | $8.54 | 0.00% | |
| CRMD | CorMedix Inc. | $799.65M | $12.14 | 0.65% | |
| CDMO | Avid Bioservices, Inc. | $798.90M | $12.49 | 0.00% | |
| NAGE | Niagen Bioscience Inc | $795.18M | $10.82 | 0.00% | |
| GERN | Geron Corporation | $777.04M | $1.52 | 2.70% | |
| LENZ | LENZ Therapeutics, Inc. | $776.91M | $29.20 | 1.12% | |
| PRAX | Praxis Precision Medicines, Inc. | $741.64M | $38.55 | 0.26% | |
| NRIX | Nurix Therapeutics, Inc. | $727.67M | $10.63 | 0.09% | |
| NUVB | Nuvation Bio Inc. | $717.54M | $2.12 | 6.19% | |
| BCAX | Bicara Therapeutics Inc. Common Stock | $711.15M | $9.25 | 2.01% | |
| AVXL | Anavex Life Sciences Corp. | $693.22M | $7.53 | 1.31% | |
| EOLS | Evolus, Inc. | $666.68M | $9.19 | 1.61% | |
| IMNM | Immunome, Inc. | $656.07M | $8.76 | 2.12% | |
| AKBA | Akebia Therapeutics, Inc. | $651.34M | $3.03 | 0.66% | |
| AVBP | ArriVent BioPharma, Inc. Common Stock | $650.26M | $21.25 | 1.19% | |
| RCKT | Rocket Pharmaceuticals, Inc. | $649.66M | $2.51 | 4.20% | |
| TRVI | Trevi Therapeutics, Inc. | $645.57M | $6.51 | 2.36% | |
| DAWN | Day One Biopharmaceuticals, Inc. | $635.03M | $6.38 | 1.54% | |
| FLGT | Fulgent Genetics, Inc. | $613.44M | $20.72 | 0.53% | |
| ABUS | Arbutus Biopharma Corporation | $610.82M | $3.36 | 2.33% | |
| ANAB | AnaptysBio, Inc. | $602.89M | $22.23 | 1.46% | |
| BBNX | Beta Bionics, Inc. | $572.30M | $17.24 | 12.24% | |
| IOVA | Iovance Biotherapeutics, Inc. | $564.35M | $1.75 | 4.37% | |
| COGT | Cogent Biosciences, Inc. | $563.59M | $5.44 | 1.27% | |
| KALV | KalVista Pharmaceuticals, Inc. | $561.29M | $11.80 | 0.76% | |
| RGLS | Regulus Therapeutics Inc. | $543.14M | $7.93 | 0.13% | |
| REPL | Replimune Group, Inc. | $541.80M | $8.98 | 4.16% | |
| KROS | Keros Therapeutics, Inc. | $539.78M | $14.15 | 0.93% | |
| SION | Sionna Therapeutics, Inc. | $539.20M | $13.69 | 2.98% | |
| NPCE | NeuroPace, Inc. | $515.69M | $13.22 | 0.84% | |
| TYRA | Tyra Biosciences, Inc. | $506.48M | $9.10 | 1.62% | |
| SVRA | Savara Inc. | $500.11M | $2.28 | 1.79% | |
| AXGN | AxoGen, Inc. | $495.52M | $10.89 | 0.09% | |
| KURA | Kura Oncology, Inc. | $489.58M | $5.69 | 2.23% | |
| MNMD | Mind Medicine (MindMed) Inc. | $485.81M | $7.26 | 0.00% | |
| STOK | Stoke Therapeutics, Inc. | $481.00M | $9.54 | 1.95% | |
| RLAY | Relay Therapeutics, Inc. | $477.47M | $3.00 | 2.60% | |
| TSHA | Taysha Gene Therapies, Inc. | $472.65M | $2.71 | 1.45% | |
| DNA | Ginkgo Bioworks Holdings, Inc. | $470.60M | $6.95 | 4.14% | |
| ARVN | Arvinas, Inc. | $459.12M | $7.20 | 4.00% | |
| GPCR | Structure Therapeutics Inc. | $449.92M | $21.76 | 2.94% | |
| CGEM | Cullinan Oncology, Inc. | $449.69M | $8.64 | 0.40% | |
| ALT | Altimmune, Inc. | $443.60M | $5.43 | 3.21% | |
| PSNL | Personalis, Inc. | $430.58M | $4.63 | 0.87% | |
| TMCI | Treace Medical Concepts, Inc. | $423.04M | $5.74 | 2.05% | |
| SIGA | SIGA Technologies, Inc. | $422.46M | $5.98 | 2.92% | |
| RGNX | REGENXBIO Inc. | $419.34M | $8.85 | 1.34% | |
| LAB | Standard BioTools Inc. | $417.80M | $1.01 | 4.72% | |
| SAGE | Sage Therapeutics, Inc. | $402.34M | $6.46 | 0.92% | |
| PRTC | PureTech Health plc | $401.60M | $18.43 | 1.74% | |
| AMLX | Amylyx Pharmaceuticals, Inc. | $400.24M | $5.15 | 5.10% | |
| SRDX | Surmodics, Inc. | $399.09M | $29.02 | 1.73% | |
| ERAS | Erasca, Inc. | $396.60M | $1.40 | 3.11% | |
| SANA | Sana Biotechnology, Inc. | $395.85M | $2.17 | 4.41% | |
| ORGO | Organogenesis Holdings Inc. | $393.88M | $2.74 | 3.86% | |
| SEPN | Septerna, Inc. | $391.74M | $9.25 | 6.19% | |
| PGEN | Precigen, Inc. | $391.09M | $1.32 | 5.04% | |
| MAZE | Maze Therapeutics, Inc. | $389.35M | $10.01 | 17.75% | |
| TRML | Tourmaline Bio, Inc. | $389.18M | $16.68 | 1.03% | |
| EYPT | EyePoint Pharmaceuticals, Inc. | $389.10M | $7.24 | 0.42% | |
| ANGO | AngioDynamics, Inc. | $381.71M | $10.20 | 2.00% | |
| ABSI | Absci Corporation | $377.54M | $2.65 | 3.28% | |
| SENS | Senseonics Holdings, Inc. | $376.28M | $0.52 | 1.95% | |
| MYGN | Myriad Genetics, Inc. | $373.78M | $4.19 | 0.72% | |
| MGTX | MeiraGTx Holdings plc | $369.44M | $5.12 | 4.48% | |
| TECX | Tectonic Therapeutic, Inc. | $368.88M | $21.51 | 3.97% | |
| CTKB | Cytek Biosciences, Inc. | $363.51M | $2.77 | 6.95% | |
| ORIC | ORIC Pharmaceuticals, Inc. | $346.20M | $8.17 | 2.51% | |
| CYRX | Cryoport, Inc. | $342.69M | $6.01 | 1.01% | |
| MBX | MBX Biosciences, Inc. Common Stock | $340.09M | $12.42 | 2.36% | |
| BNTC | Benitec Biopharma Inc. | $336.70M | $15.36 | 1.48% | |
| PACB | Pacific Biosciences of California, Inc. | $334.59M | $0.96 | 7.34% | |
| CAPR | Capricor Therapeutics, Inc. | $333.44M | $9.89 | 1.98% | |
| RIGL | Rigel Pharmaceuticals, Inc. | $323.85M | $19.20 | 1.69% | |
| ARCT | Arcturus Therapeutics Holdings Inc. | $321.65M | $12.53 | 1.57% |